Chemotherapy-induced peripheral neuropathy is a common adverse event which affects the sensory, motor and autonomic nerves.

The diagnosis of chemotherapy-induced peripheral neuropathy lacks a gold standard.

There are currently no proven strategies or interventions to prevent or limit the development of chemotherapy-induced peripheral neuropathy.

A mechanistic approach is needed to address strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy.